. 3 doses of mRNA COVID vaccine show advantage against severe outcomes - IOPAC Press "Enter" to skip to content

Attacks on hospitals and health workers jeopardize provision of health in Lebanon
- All WHO news
Since the escalation of hostilities between Israel and Lebanon on 17 September 2024, WHO has verified 23 attacks on health...
US$ 1 billion in new and reaffirmed funding commitments announced for WHO’s ongoing Investment Round
- All WHO news
In a powerful demonstration of high-level support, the World Health Organization (WHO) today received nearly US$ 700 million in new...
WHO Youth Council releases bold call for a healthier world
- All WHO news
The WHO Youth Council has launched its first Youth Declaration on Creating Healthy Societies, with a range of calls to...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

3 doses of mRNA COVID vaccine show advantage against severe outcomes

By iopac on October 15, 2024

Fourteen to 60 days postvaccination, third-dose relative vaccine effectiveness against hospitalization was 77% for Moderna and 73% for Pfizer.

Published in COVID-19

iopac